If you experience severe pain, significant swelling, signs of infection (increasing redness, warmth, purulent drainage), or signs of allergic reaction (trouble breathing, facial/throat swelling, severe rash), contact your healthcare provider promptly for assessment

usually improves over several weeks Diarrhoea or constipation : Altered bowel habits due to delayed gastric emptying Abdominal discomfort : Bloating, dyspepsia, or gastro-oesophageal reflux symptoms Practical management strategies recommended by NICE and specialist diabetes services include: Starting at the lowest licensed dose and titrating gradually according to the product's summary of product characteristics Eating smaller, more frequent meals and avoiding high-fat foods Maintaining adequate hydration, particularly if experiencing vomiting or diarrhoea Taking the injection at a consistent time as specified in the SmPC for your particular medication Less common but important adverse effects include: Injection site reactions : Rotate injection sites systematically between abdomen, thigh, and upper arm to minimise localised reactions Hypoglycaemia : Risk increases when GLP-1 agents are combined with insulin or sulphonylureas

However, long-term safety data including cardiovascular outcomes, heart-rate effects, and optimal dosing are still being gathered in Phase 3 studies, and no definitive safety conclusions can be drawn at this stage
[23] This typically manifests as mild to moderate queasiness that may be more pronounced after meals
Visit our website to sign up